Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuxi Zhongkun Biochemical Technology is a specialized biotechnology company focused on the production of high-quality biochemical reagents and diagnostic raw materials. The company is a prominent manufacturer of enzymes used in clinical diagnostics, including thrombin, heparinase, and chondroitinase. These products are essential for applications in blood coagulation research, heparin testing, and glycosaminoglycan analysis. Headquartered in Wuxi, China, the firm provides critical components to the global in vitro diagnostics (IVD) and pharmaceutical research sectors. Their manufacturing processes emphasize high purity and activity, catering to both domestic and international markets. The company also offers customized enzyme preparation services to meet specific research requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuxi Zhongkun Biochemical Technology.